• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Notch-4基因沉默通过NF-κB信号通路抑制前列腺癌生长和上皮间质转化。

Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.

作者信息

Zhang Jianwei, Kuang Youlin, Wang Yan, Xu Quanquan, Ren Qinghua

机构信息

Department of Urology Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.

Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

出版信息

Apoptosis. 2017 Jun;22(6):877-884. doi: 10.1007/s10495-017-1368-0.

DOI:10.1007/s10495-017-1368-0
PMID:28374086
Abstract

Epithelial-mesenchymal transition (EMT) is implicated in the metastasis of human prostate cancer (PCa). Notch signaling has been established as a regulator of EMT. Notch-4 has emerged as a mammary proto-oncogene and a target in several cancers. However, the role and the mechanism of action of Notch-4 in PCa are still unclear. In the present study, we first observed a marked increase in Notch-4 expression in the PCa cell lines DU145, PC3 and LnCAP compared with the non-malignant prostate epithelial cell line RWPE1. Knocking down the expression of Notch-4 suppressed the viability and proliferation in the PCa cell lines DU145 and PC3. Also, further study showed that a decline in Notch-4 significantly promoted apoptosis in PC3 cells. Notch-4 silencing also resulted in decreased cell migration and invasion and affected the expression of EMT markers. We hypothesized that Notch-4 ablation suppresses the activity of NF-κB, so we used PMA to stimulate NF-κB p50 and p65 activation in PC3 cells. The results indicate that PMA treatment impaired the action of Notch-4 ablation in the biology of PC3 cells including cell growth, apoptosis, migration, invasion and EMT. The results of the present study show that RNAi targeting against Notch-4 expression suppresses PCa progression.

摘要

上皮-间质转化(EMT)与人类前列腺癌(PCa)的转移有关。Notch信号通路已被确认为EMT的调节因子。Notch-4已成为一种乳腺原癌基因和多种癌症的靶点。然而,Notch-4在PCa中的作用和作用机制仍不清楚。在本研究中,我们首先观察到与非恶性前列腺上皮细胞系RWPE1相比,PCa细胞系DU145、PC3和LnCAP中Notch-4的表达显著增加。敲低Notch-4的表达可抑制PCa细胞系DU145和PC3的活力和增殖。此外,进一步研究表明,Notch-4的下降显著促进了PC3细胞的凋亡。Notch-4沉默还导致细胞迁移和侵袭减少,并影响EMT标志物的表达。我们假设Notch-4缺失会抑制NF-κB的活性,因此我们使用佛波酯(PMA)刺激PC3细胞中NF-κB p50和p65的激活。结果表明,PMA处理削弱了Notch-4缺失对PC3细胞生物学行为(包括细胞生长、凋亡、迁移、侵袭和EMT)的作用。本研究结果表明,靶向Notch-4表达的RNA干扰可抑制PCa的进展。

相似文献

1
Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.Notch-4基因沉默通过NF-κB信号通路抑制前列腺癌生长和上皮间质转化。
Apoptosis. 2017 Jun;22(6):877-884. doi: 10.1007/s10495-017-1368-0.
2
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.E-钙黏蛋白的下调通过Notch信号通路增强前列腺癌的化疗耐药性。
Chin J Cancer. 2017 Mar 29;36(1):35. doi: 10.1186/s40880-017-0203-x.
3
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.致癌性 miR-210-3p 通过 NF-κB 信号通路促进前列腺癌细胞 EMT 和骨转移。
Mol Cancer. 2017 Jul 10;16(1):117. doi: 10.1186/s12943-017-0688-6.
4
Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.Notch-1和Jagged-1的下调抑制前列腺癌细胞的生长、迁移和侵袭,并通过使Akt、mTOR和NF-κB信号通路失活诱导细胞凋亡。
J Cell Biochem. 2010 Mar 1;109(4):726-36. doi: 10.1002/jcb.22451.
5
Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.白藜芦醇诱导 TRAF6 的耗竭,抑制前列腺癌细胞的增殖和迁移。
Int J Biochem Cell Biol. 2020 Jan;118:105644. doi: 10.1016/j.biocel.2019.105644. Epub 2019 Nov 9.
6
High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.高迁移率族蛋白 B1 通过 RAGE/NF-κB 信号通路促进前列腺癌细胞 PC3 的上皮间质转化。
Int J Oncol. 2018 Aug;53(2):659-671. doi: 10.3892/ijo.2018.4420. Epub 2018 May 23.
7
The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).泛素连接酶UBE4A通过靶向白细胞介素样上皮-间质转化诱导因子(ILEI)抑制前列腺癌进展。
IUBMB Life. 2017 Jan;69(1):16-21. doi: 10.1002/iub.1585. Epub 2016 Nov 10.
8
Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells.Notch信号通路的激活与前列腺癌细胞的上皮-间质转化有关。
Cell Cycle. 2017 May 19;16(10):999-1007. doi: 10.1080/15384101.2017.1312237. Epub 2017 Apr 7.
9
Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling.口疮性溃疡药物通过靶向 IKKɛ/TBK1/NF-κB 信号通路抑制前列腺肿瘤转移。
Theranostics. 2018 Sep 9;8(17):4633-4648. doi: 10.7150/thno.26687. eCollection 2018.
10
Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.脂质运载蛋白2的过表达通过激活ERK信号通路增加前列腺癌中SLUG的表达,从而促进细胞迁移和侵袭。
Prostate. 2015 Jun 15;75(9):957-68. doi: 10.1002/pros.22978. Epub 2015 Feb 25.

引用本文的文献

1
Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer.间充质干细胞中Cxcl1的靶向缺失调节成骨作用并抑制骨转移性前列腺癌。
Mol Cancer Res. 2025 Aug 4;23(8):739-758. doi: 10.1158/1541-7786.MCR-24-0672.
2
NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway.NOTCH3 通过调控 TUBB3 和 MAPK 信号通路促进前列腺癌细胞对多西紫杉醇的耐药性。
Cancer Sci. 2024 Feb;115(2):412-426. doi: 10.1111/cas.16040. Epub 2023 Dec 20.
3
Nuclear factor kappa B expression in non-small cell lung cancer.
核因子 kappa B 在非小细胞肺癌中的表达。
Biomed Pharmacother. 2023 Nov;167:115459. doi: 10.1016/j.biopha.2023.115459. Epub 2023 Sep 15.
4
SNTB1 regulates colorectal cancer cell proliferation and metastasis through YAP1 and the WNT/β-catenin pathway.SNTB1 通过 YAP1 和 WNT/β-catenin 通路调节结直肠癌细胞的增殖和转移。
Cell Cycle. 2023 Sep;22(17):1865-1883. doi: 10.1080/15384101.2023.2244778. Epub 2023 Aug 17.
5
Pancreatic cancer stemness: dynamic status in malignant progression.胰腺癌干细胞特性:恶性进展中的动态状态。
J Exp Clin Cancer Res. 2023 May 13;42(1):122. doi: 10.1186/s13046-023-02693-2.
6
The Clinical Application of Immunohistochemical Expression of Notch4 Protein in Patients with Colon Adenocarcinoma. Notch4 蛋白免疫组织化学表达在结肠癌患者中的临床应用。
Int J Mol Sci. 2023 Apr 19;24(8):7502. doi: 10.3390/ijms24087502.
7
Notch signaling, hypoxia, and cancer.Notch信号通路、缺氧与癌症。
Front Oncol. 2023 Jan 31;13:1078768. doi: 10.3389/fonc.2023.1078768. eCollection 2023.
8
SOX8 Knockdown Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting the Notch Signaling Pathway.SOX8 敲低通过抑制 Notch 信号通路克服去势抵抗性前列腺癌中的恩杂鲁胺耐药性。
Biomed Res Int. 2022 Oct 6;2022:9235837. doi: 10.1155/2022/9235837. eCollection 2022.
9
Preclinical In Vitro Model to Assess the Changes in Permeability and Cytotoxicity of Polarized Intestinal Epithelial Cells during Exposure Mimicking Oral or Intravenous Routes: An Example of Arsenite Exposure.评估模拟口服或静脉途径暴露时极性肠道上皮细胞通透性和细胞毒性变化的临床前体外模型:以亚砷酸盐暴露为例。
Int J Mol Sci. 2022 Apr 27;23(9):4851. doi: 10.3390/ijms23094851.
10
Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancer.靶向雄激素剥夺治疗抵抗性前列腺癌中 BRD4 和 CBP/p300 共激活的 CDCP1 基因转录。
Oncogene. 2022 Jun;41(23):3251-3262. doi: 10.1038/s41388-022-02327-5. Epub 2022 May 5.